SNT
6319
Flight Solutions
3753
Kyorin Pharmaceutical
4569
FFRI Security
3692
Asterisk
6522
(Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.81%55.69B | -5.13%46.23B | 7.45%221.99B | 6.08%65.82B | 4.83%52.63B | 9.65%54.81B | 9.84%48.73B | 0.72%206.6B | 8.76%62.05B | 9.78%50.21B |
Cost of revenue | -4.51%25.17B | -0.02%24.37B | 9.90%110.64B | 10.59%32.75B | 8.42%26.36B | 12.21%27.16B | 8.09%24.38B | 4.82%100.68B | 9.07%29.62B | 15.57%24.31B |
Gross profit | 16.17%30.53B | -10.25%21.86B | 5.12%111.35B | 1.95%33.06B | 1.46%26.28B | 7.24%27.65B | 11.65%24.35B | -2.90%105.93B | 8.47%32.43B | 4.85%25.9B |
Operating expense | 6.24%24.71B | 4.33%23.11B | 8.20%91.76B | 5.73%23.99B | 6.96%23.25B | 9.72%22.37B | 10.77%22.15B | 8.59%84.81B | 2.10%22.69B | 15.64%21.74B |
Operating profit | 92.46%5.82B | -156.57%-1.25B | -7.24%19.59B | -6.85%9.08B | -27.33%3.02B | -2.11%5.29B | 21.34%2.21B | -31.85%21.12B | 26.93%9.74B | -29.50%4.16B |
Net non-operating interest income (expenses) | -9.84%55M | 0.00%49M | 44.02%265M | 65.08%104M | 19.61%61M | 50.00%51M | 36.11%49M | 52.07%184M | 0.00%63M | 75.86%51M |
Non-operating interest income | 45.16%90M | 9.62%57M | 48.97%289M | 76.47%120M | 19.23%62M | 48.65%55M | 40.54%52M | 46.97%194M | -2.86%68M | 73.33%52M |
Non-operating interest expense | 3,400.00%35M | 166.67%8M | 140.00%24M | 220.00%16M | 0.00%1M | 33.33%4M | 200.00%3M | -9.09%10M | -28.57%5M | 0.00%1M |
Net investment income | 320.20%5.43B | -21.79%2.81B | 119.56%5.5B | 793.81%3.03B | 28.11%-2.47B | -32.43%1.35B | -0.39%3.59B | -23.67%2.51B | -84.63%339M | -574.27%-3.43B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -360.00%-23M | 98.73%-1M | -109.09%-92M | 88.57%-8M | -105.05%-5M | 0 | -1,480.00%-79M | 87.02%-44M | 79.53%-70M | 3,400.00%99M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 33.33%-2M | -400.00%-5M | 462.54%3.77B | 458.28%3.77B | 57.14%-3M | 0.00%-1M | -150.00%-1M | 1,775.00%670M | 7,411.11%676M | -40.00%-7M |
Less:Restructuring and mergern&acquisition | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Other special charges | -33.33%2M | 400.00%5M | -487.61%-3.94B | -483.14%-3.94B | -57.14%3M | 0.00%1M | 150.00%1M | -1,775.00%-670M | -7,411.11%-676M | 40.00%7M |
Less:Write off | ---- | ---- | --168M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Other non-operating income (expenses) | -13.27%85M | 139.29%67M | 20.94%335M | 89.04%138M | 151.28%98M | -47.79%71M | -3.45%28M | 12.15%277M | 192.00%73M | 5.41%39M |
Income before tax | 1,500.85%11.37B | -71.19%1.67B | 18.83%29.37B | 48.85%16.11B | -22.40%710M | -9.89%6.75B | 5.67%5.79B | -27.86%24.72B | 12.36%10.83B | -86.31%915M |
Income tax | 372.60%3.69B | -55.03%902M | 62.27%12.34B | 172.24%7.01B | 31.04%781M | -3.38%2.54B | 11.26%2.01B | -29.75%7.61B | -17.20%2.58B | -71.15%596M |
Net income | 10,908.45%7.67B | -79.77%766M | -0.49%17.03B | 10.30%9.1B | -122.26%-71M | -13.41%4.21B | 2.94%3.79B | -26.99%17.11B | 26.46%8.25B | -93.09%319M |
Net income continuous operations | 10,909.86%7.68B | -79.75%767M | -0.49%17.03B | 10.32%9.1B | -122.26%-71M | -13.41%4.21B | 2.93%3.79B | -26.99%17.11B | 26.46%8.25B | -93.09%319M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 10,908.45%7.67B | -79.77%766M | -0.49%17.03B | 10.30%9.1B | -122.26%-71M | -13.41%4.21B | 2.94%3.79B | -26.99%17.11B | 26.46%8.25B | -93.09%319M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 10,908.45%7.67B | -79.77%766M | -0.49%17.03B | 10.30%9.1B | -122.26%-71M | -13.41%4.21B | 2.94%3.79B | -26.99%17.11B | 26.46%8.25B | -93.09%319M |
Gross dividend payment | ||||||||||
Basic earnings per share | 10,800.00%46.01 | -79.70%4.57 | -0.41%101.225 | 10.43%54.125 | -122.51%-0.43 | -13.38%25.02 | 3.11%22.51 | -26.48%101.64 | 27.06%49.015 | -92.99%1.91 |
Diluted earnings per share | 10,800.00%46.01 | -79.70%4.57 | -0.41%101.225 | 10.43%54.125 | -122.68%-0.43 | -13.38%25.02 | 3.11%22.51 | -26.48%101.64 | 27.06%49.015 | -93.04%1.896 |
Dividend per share | 0 | 0 | 0.00%30.5 | -24.39%15.5 | 0 | 50.00%15 | 0 | 56.41%30.5 | 105.00%20.5 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |